13 research outputs found
Plasticity of motor representations in patients with brain lesions: a navigated TMS study
Correlation between the distance of the corticospinal tract to the tumor and clinical outcome: A combined nTMS - fiber tacking approach
Clinical factors affecting the resting motor threshold in preoperative nTMS motor mapping
Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial
Cognitive deficits and negative symptoms in schizophrenia are associated with poor functional outcomes and limited in terms of treatment. The Schizophrenia Treatment With Electric Transcranial Stimulation (STARTS) trial has shown efficacy of transcranial direct current stimulation (tDCS) for improving negative symptoms. In this secondary analysis, we investigate its effects on cognitive performance. In STARTS, a double-blinded, sham controlled, randomized clinical trial, patients were treated with twice-daily, 20-min, 2-mA fronto-temporal tDCS over 5 days or sham-tDCS. In 90 patients, we evaluated the cognitive performance up to 12 weeks post-treatment. We found that active-tDCS showed no beneficial effects over sham-tDCS in any of the tests. Based on a 5-factor cognitive model, improvements of executive functions and delayed memory were observed in favor of shamtDCS. Overall, the applied active-tDCS protocol, primarily designed to improve negative symptoms, did not promote cognitive improvement. We discuss possible protocol modification potentially required to increase tDCS effects on cognition. ClinicalTrials.gov identifier: NCT0253567
Reduced fields show up in schizophrenia and major depression: a prefrontal tDCS simulation study
CONCURRENT TMS-fMRI - SYSTEMATIC REVIEW OF METHODOLOGICAL DIFFERENCES AND SOURCES OF BIAS
The intervention, the patient and the illness : personalizing non-invasive brain stimulation in psychiatry
202206 bcchNot applicableOthersFederal Ministry of Education and Research; São Paulo Research State Foundation; German Research Foundation; European Collaboration Project PRONIAPublished12 month
Effects of prefrontal cathodal tDCS on brain glutamate levels and resting state connectivity: A randomized, sham-controlled, cross-over trial in healthy volunteers
Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial
Functional and structural MRI of prefrontal cortex (PFC) may provide putative biomarkers for predicting the treatment response to transcranial direct current stimulation (tDCS) in depression. A recent MRI study from ELECT-TDCS (Escitalopram versus Electrical Direct-Current Theror Depression Study) showed that depression improvement after tDCS was associated with gray matter volumes of PFC subregions. Based thereon, we investigated whether antidepressant effects of tDCS are similarly associated with baseline resting-state functional connectivity (rsFC). A subgroup of 51 patients underwent baseline rsFC-MRI. All patients of ELECT-TDCS were randomized to three treatment arms for 10 weeks (anodal-left, cathodal-right PFC tDCS plus placebo medication; escitalopram 10 mg/day for 3 weeks and 20 mg/day thereafter plus sham tDCS; and placebo medication plus sham tDCS). RsFC was calculated for various PFC regions and analyzed in relation to the individual antidepressant response. There was no significant association between baseline PFC connectivity of essential structural regions, nor any other PFC regions (after correction for multiple comparisons) and patients' individual antidepressant response. This study did not reveal an association between antidepressants effects of tDCS and baseline rsFC, unlike the gray matter volume findings. Thus, the antidepressant effects of tDCS may be differentially related to structural and functional MRI measurements